Role of CD8+ T Cells in TMEV Resistance and Susceptibili
CD8 T 细胞在 TMEV 耐药性和易感性中的作用
基本信息
- 批准号:6562284
- 负责人:
- 金额:$ 14.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-01 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:MHC class I antigen cell line cell proliferation cellular immunity cytokine cytotoxic T lymphocyte disease /disorder model gene expression genetic susceptibility genetically modified animals helper T lymphocyte immunoregulation laboratory mouse multiple sclerosis murine encephalomyelitis virus mutant myelination pathologic process recombinant virus transfection viral myelinopathy virus antigen virus genetics virus infection mechanism virus protein
项目摘要
Description (provided by applicant)
ntracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV) results in chronic
inflammatory demyelination leading to clinical symptoms in susceptible mice. In light of the potential viral etiology and similarities in the progression of chronic demyelination, this TMEV system is considered to be one of the best animal models for studying human multiple sclerosis (MS). Extensive studies on the class II-restricted, CD4+ T cell response specific for TMEV, which appears to play an important role in viral pathogenesis, have been reported. Using X32-microglobulin and perforin deficient mice lacking cytotoxic T cell function, we have demonstrated that cytotoxic function is important for protection from this virus-induced demyelinating disease in resistant mice with the C57BL/6 background. However, very little is known about the class I-restricted, CD8+ T cell response against TMEV particularly in susceptible strains, although this type of response is known to be the most efficient in protecting the host from viral infections. During the past grant period, we have identified one major and two minor H-2Db-restricted CTL epitopes for resistant C57BL/6 mice, and similarly one predominant and two subdominant H-2Ks-restricted CTL epitopes for susceptible SJL/J mice using
overlapping peptides of the entire capsid proteins of TMEV. Because resistance to TMEV-induced demyelination is associated with the H2D locus and susceptible mice lack virus-specific, H-2Drestricted cytotoxic T cells, we speculate that the efficiency and/or frequency of virus-specific CD8+ cytotoxic T cells may be dependent on the differences in the class I restriction between resistant and susceptible mice. We propose here to examine the role and fate of these cytotoxic T cells specific for the predominant and subdominant viral epitopes in resistance and/or susceptibility to Theiler's virusinduced demyelinating disease as a model for human multiple sclerosis. The specific aims for the proposed studies include: 1) To assess the level and fate of CD8+ T cells specific for viral epitopes in resistant and susceptible mice during the course of demyelinating disease; 2) To determine the role of virus-specific CD8+ T cells in protection from and/or pathogenesis of TMEV-induced demyelinating disease; 3) To examine the significance of H-2D vs H-2K-restriction for TMEV-specific CTL in resistance/susceptibility and the potential mechanism of this skewed restriction. We believe that our proposed studies will yield important information on the potential control mechanism(s) against virusinduced,
immune-mediated demyelination, which is a relevant animal model for studying human MS.
说明(申请人提供)
脑内接种Theiler小鼠脑脊髓炎病毒(TMEV)导致慢性
炎性脱髓鞘导致易感小鼠的临床症状。鉴于潜在的病毒病因学和慢性脱髓鞘进展的相似性,该TMEV系统被认为是研究人类多发性硬化症(MS)的最佳动物模型之一。已经报道了对TMEV特异性的II类限制性CD 4 + T细胞应答的广泛研究,其似乎在病毒发病机制中起重要作用。使用X32-微球蛋白和穿孔素缺陷小鼠缺乏细胞毒性T细胞功能,我们已经证明,细胞毒性功能是重要的保护,从这种病毒诱导的脱髓鞘疾病的耐药小鼠与C57 BL/6的背景。然而,关于针对TMEV的I类限制性CD 8 + T细胞应答(特别是在易感株中)知之甚少,尽管已知这种类型的应答在保护宿主免受病毒感染方面最有效。在过去的资助期间,我们已经确定了一个主要的和两个次要的H-2Db限制性CTL表位的耐药C57 BL/6小鼠,以及类似的一个主要的和两个亚显性H-2KS限制性CTL表位的敏感SJL/J小鼠,使用
TMEV的整个衣壳蛋白的重叠肽。由于对TMEV诱导的脱髓鞘的抗性与H2 D位点相关,并且易感小鼠缺乏病毒特异性H-2D限制性细胞毒性T细胞,我们推测病毒特异性CD 8+细胞毒性T细胞的效率和/或频率可能取决于抗性小鼠和易感小鼠之间I类限制的差异。我们建议在这里检查的作用和命运的细胞毒性T细胞的特异性的优势和亚优势的病毒表位的阻力和/或易感性泰勒病毒引起的脱髓鞘疾病作为人类多发性硬化症的模型。拟开展的研究的具体目的包括:1)评估脱髓鞘疾病过程中耐药和易感小鼠中病毒表位特异性CD 8 + T细胞的水平和命运; 2)确定病毒特异性CD 8 + T细胞在TMEV诱导的脱髓鞘疾病的预防和/或发病机制中的作用;(3)探讨TMEV特异性CTL H-2D和H-2K限制在TMEV耐药/易感性中的意义以及这种偏斜限制的可能机制。我们相信,我们提出的研究将产生关于抗病毒诱导的潜在控制机制的重要信息,
免疫介导的脱髓鞘,这是研究人类MS的相关动物模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BYUNG S KIM其他文献
BYUNG S KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BYUNG S KIM', 18)}}的其他基金
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6565215 - 财政年份:2001
- 资助金额:
$ 14.5万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6410633 - 财政年份:2000
- 资助金额:
$ 14.5万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6302773 - 财政年份:1999
- 资助金额:
$ 14.5万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6112251 - 财政年份:1998
- 资助金额:
$ 14.5万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6273739 - 财政年份:1997
- 资助金额:
$ 14.5万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
7114307 - 财政年份:1994
- 资助金额:
$ 14.5万 - 项目类别:
T CELL RECEPTORS INVOLVED IN TMEV INDUCED DEMYELINATION
T 细胞受体参与 TMEV 诱导的脱髓鞘
- 批准号:
6051065 - 财政年份:1994
- 资助金额:
$ 14.5万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
6869030 - 财政年份:1994
- 资助金额:
$ 14.5万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
7503372 - 财政年份:1994
- 资助金额:
$ 14.5万 - 项目类别:
T-CELL RECEPTORS INVOLVED IN TMEV-INDUCED DEMYELINATION
T 细胞受体参与 TMEV 诱导的脱髓鞘
- 批准号:
2271542 - 财政年份:1994
- 资助金额:
$ 14.5万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 14.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 14.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 14.5万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 14.5万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 14.5万 - 项目类别:
Studentship














{{item.name}}会员




